
The global Computer Aided Diagnostics (CADx) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Computer Aided Diagnostics (CADx), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer Aided Diagnostics (CADx).
Report Scope
The Computer Aided Diagnostics (CADx) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computer Aided Diagnostics (CADx) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer Aided Diagnostics (CADx) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cadens Medical Imaging
EDDA Technology, Inc.
Fujifilm
GE Healthcare
Hologic Inc.
iCAD Inc.
Invivo Corporation
Koninklijke Philips N.V.
Median Technologies
Merge Healthcare Inc.
Neusoft Corporation
Parascript LLC
Riverain Technologies
Samsung Medison.
Siemens Healthineers
Agfa Healthcare
Segment by Type
Mammography
Magnetic Resonance Imaging (MRI)
Ultrasound
Tomosynthesis
Computed Tomography (CT)
Segment by Application
Oncology
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer Aided Diagnostics (CADx) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer Aided Diagnostics (CADx) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mammography
1.2.3 Magnetic Resonance Imaging (MRI)
1.2.4 Ultrasound
1.2.5 Tomosynthesis
1.2.6 Computed Tomography (CT)
1.3 Market by Application
1.3.1 Global Computer Aided Diagnostics (CADx) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Other Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer Aided Diagnostics (CADx) Market Perspective (2019-2030)
2.2 Computer Aided Diagnostics (CADx) Growth Trends by Region
2.2.1 Global Computer Aided Diagnostics (CADx) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computer Aided Diagnostics (CADx) Historic Market Size by Region (2019-2024)
2.2.3 Computer Aided Diagnostics (CADx) Forecasted Market Size by Region (2025-2030)
2.3 Computer Aided Diagnostics (CADx) Market Dynamics
2.3.1 Computer Aided Diagnostics (CADx) Industry Trends
2.3.2 Computer Aided Diagnostics (CADx) Market Drivers
2.3.3 Computer Aided Diagnostics (CADx) Market Challenges
2.3.4 Computer Aided Diagnostics (CADx) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer Aided Diagnostics (CADx) Players by Revenue
3.1.1 Global Top Computer Aided Diagnostics (CADx) Players by Revenue (2019-2024)
3.1.2 Global Computer Aided Diagnostics (CADx) Revenue Market Share by Players (2019-2024)
3.2 Global Computer Aided Diagnostics (CADx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer Aided Diagnostics (CADx) Revenue
3.4 Global Computer Aided Diagnostics (CADx) Market Concentration Ratio
3.4.1 Global Computer Aided Diagnostics (CADx) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer Aided Diagnostics (CADx) Revenue in 2023
3.5 Computer Aided Diagnostics (CADx) Key Players Head office and Area Served
3.6 Key Players Computer Aided Diagnostics (CADx) Product Solution and Service
3.7 Date of Enter into Computer Aided Diagnostics (CADx) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer Aided Diagnostics (CADx) Breakdown Data by Type
4.1 Global Computer Aided Diagnostics (CADx) Historic Market Size by Type (2019-2024)
4.2 Global Computer Aided Diagnostics (CADx) Forecasted Market Size by Type (2025-2030)
5 Computer Aided Diagnostics (CADx) Breakdown Data by Application
5.1 Global Computer Aided Diagnostics (CADx) Historic Market Size by Application (2019-2024)
5.2 Global Computer Aided Diagnostics (CADx) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computer Aided Diagnostics (CADx) Market Size (2019-2030)
6.2 North America Computer Aided Diagnostics (CADx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computer Aided Diagnostics (CADx) Market Size by Country (2019-2024)
6.4 North America Computer Aided Diagnostics (CADx) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer Aided Diagnostics (CADx) Market Size (2019-2030)
7.2 Europe Computer Aided Diagnostics (CADx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computer Aided Diagnostics (CADx) Market Size by Country (2019-2024)
7.4 Europe Computer Aided Diagnostics (CADx) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer Aided Diagnostics (CADx) Market Size (2019-2030)
8.2 Asia-Pacific Computer Aided Diagnostics (CADx) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computer Aided Diagnostics (CADx) Market Size by Region (2019-2024)
8.4 Asia-Pacific Computer Aided Diagnostics (CADx) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer Aided Diagnostics (CADx) Market Size (2019-2030)
9.2 Latin America Computer Aided Diagnostics (CADx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computer Aided Diagnostics (CADx) Market Size by Country (2019-2024)
9.4 Latin America Computer Aided Diagnostics (CADx) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer Aided Diagnostics (CADx) Market Size (2019-2030)
10.2 Middle East & Africa Computer Aided Diagnostics (CADx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computer Aided Diagnostics (CADx) Market Size by Country (2019-2024)
10.4 Middle East & Africa Computer Aided Diagnostics (CADx) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cadens Medical Imaging
11.1.1 Cadens Medical Imaging Company Detail
11.1.2 Cadens Medical Imaging Business Overview
11.1.3 Cadens Medical Imaging Computer Aided Diagnostics (CADx) Introduction
11.1.4 Cadens Medical Imaging Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.1.5 Cadens Medical Imaging Recent Development
11.2 EDDA Technology, Inc.
11.2.1 EDDA Technology, Inc. Company Detail
11.2.2 EDDA Technology, Inc. Business Overview
11.2.3 EDDA Technology, Inc. Computer Aided Diagnostics (CADx) Introduction
11.2.4 EDDA Technology, Inc. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.2.5 EDDA Technology, Inc. Recent Development
11.3 Fujifilm
11.3.1 Fujifilm Company Detail
11.3.2 Fujifilm Business Overview
11.3.3 Fujifilm Computer Aided Diagnostics (CADx) Introduction
11.3.4 Fujifilm Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.3.5 Fujifilm Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Computer Aided Diagnostics (CADx) Introduction
11.4.4 GE Healthcare Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Hologic Inc.
11.5.1 Hologic Inc. Company Detail
11.5.2 Hologic Inc. Business Overview
11.5.3 Hologic Inc. Computer Aided Diagnostics (CADx) Introduction
11.5.4 Hologic Inc. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.5.5 Hologic Inc. Recent Development
11.6 iCAD Inc.
11.6.1 iCAD Inc. Company Detail
11.6.2 iCAD Inc. Business Overview
11.6.3 iCAD Inc. Computer Aided Diagnostics (CADx) Introduction
11.6.4 iCAD Inc. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.6.5 iCAD Inc. Recent Development
11.7 Invivo Corporation
11.7.1 Invivo Corporation Company Detail
11.7.2 Invivo Corporation Business Overview
11.7.3 Invivo Corporation Computer Aided Diagnostics (CADx) Introduction
11.7.4 Invivo Corporation Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.7.5 Invivo Corporation Recent Development
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Detail
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Computer Aided Diagnostics (CADx) Introduction
11.8.4 Koninklijke Philips N.V. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.8.5 Koninklijke Philips N.V. Recent Development
11.9 Median Technologies
11.9.1 Median Technologies Company Detail
11.9.2 Median Technologies Business Overview
11.9.3 Median Technologies Computer Aided Diagnostics (CADx) Introduction
11.9.4 Median Technologies Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.9.5 Median Technologies Recent Development
11.10 Merge Healthcare Inc.
11.10.1 Merge Healthcare Inc. Company Detail
11.10.2 Merge Healthcare Inc. Business Overview
11.10.3 Merge Healthcare Inc. Computer Aided Diagnostics (CADx) Introduction
11.10.4 Merge Healthcare Inc. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.10.5 Merge Healthcare Inc. Recent Development
11.11 Neusoft Corporation
11.11.1 Neusoft Corporation Company Detail
11.11.2 Neusoft Corporation Business Overview
11.11.3 Neusoft Corporation Computer Aided Diagnostics (CADx) Introduction
11.11.4 Neusoft Corporation Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.11.5 Neusoft Corporation Recent Development
11.12 Parascript LLC
11.12.1 Parascript LLC Company Detail
11.12.2 Parascript LLC Business Overview
11.12.3 Parascript LLC Computer Aided Diagnostics (CADx) Introduction
11.12.4 Parascript LLC Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.12.5 Parascript LLC Recent Development
11.13 Riverain Technologies
11.13.1 Riverain Technologies Company Detail
11.13.2 Riverain Technologies Business Overview
11.13.3 Riverain Technologies Computer Aided Diagnostics (CADx) Introduction
11.13.4 Riverain Technologies Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.13.5 Riverain Technologies Recent Development
11.14 Samsung Medison.
11.14.1 Samsung Medison. Company Detail
11.14.2 Samsung Medison. Business Overview
11.14.3 Samsung Medison. Computer Aided Diagnostics (CADx) Introduction
11.14.4 Samsung Medison. Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.14.5 Samsung Medison. Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Detail
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Computer Aided Diagnostics (CADx) Introduction
11.15.4 Siemens Healthineers Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.15.5 Siemens Healthineers Recent Development
11.16 Agfa Healthcare
11.16.1 Agfa Healthcare Company Detail
11.16.2 Agfa Healthcare Business Overview
11.16.3 Agfa Healthcare Computer Aided Diagnostics (CADx) Introduction
11.16.4 Agfa Healthcare Revenue in Computer Aided Diagnostics (CADx) Business (2019-2024)
11.16.5 Agfa Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Cadens Medical Imaging
EDDA Technology, Inc.
Fujifilm
GE Healthcare
Hologic Inc.
iCAD Inc.
Invivo Corporation
Koninklijke Philips N.V.
Median Technologies
Merge Healthcare Inc.
Neusoft Corporation
Parascript LLC
Riverain Technologies
Samsung Medison.
Siemens Healthineers
Agfa Healthcare
Ìý
Ìý
*If Applicable.
